MX2023005040A - Vectores basados en el virus de la anemia del pollo (cav). - Google Patents
Vectores basados en el virus de la anemia del pollo (cav).Info
- Publication number
- MX2023005040A MX2023005040A MX2023005040A MX2023005040A MX2023005040A MX 2023005040 A MX2023005040 A MX 2023005040A MX 2023005040 A MX2023005040 A MX 2023005040A MX 2023005040 A MX2023005040 A MX 2023005040A MX 2023005040 A MX2023005040 A MX 2023005040A
- Authority
- MX
- Mexico
- Prior art keywords
- cav
- based vectors
- anemia virus
- chicken anemia
- chicken
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00041—Use of virus, viral particle or viral elements as a vector
- C12N2750/00043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063107149P | 2020-10-29 | 2020-10-29 | |
| US202163147087P | 2021-02-08 | 2021-02-08 | |
| PCT/US2021/057292 WO2022094238A2 (en) | 2020-10-29 | 2021-10-29 | Chicken anemia virus (cav)-based vectors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023005040A true MX2023005040A (es) | 2023-06-02 |
Family
ID=81384465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023005040A MX2023005040A (es) | 2020-10-29 | 2021-10-29 | Vectores basados en el virus de la anemia del pollo (cav). |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240000914A1 (enExample) |
| EP (1) | EP4237567A4 (enExample) |
| JP (1) | JP2023548838A (enExample) |
| KR (1) | KR20230093326A (enExample) |
| AU (1) | AU2021372533A1 (enExample) |
| CA (1) | CA3199750A1 (enExample) |
| IL (1) | IL302332A (enExample) |
| MX (1) | MX2023005040A (enExample) |
| TW (1) | TW202233652A (enExample) |
| WO (1) | WO2022094238A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3121528A1 (en) | 2018-12-12 | 2020-06-18 | Flagship Pioneering Innovations V, Inc. | Anellosomes and methods of use |
| WO2023069948A1 (en) | 2021-10-18 | 2023-04-27 | Flagship Pioneering Innovations Vii, Llc | Dna compositions and related methods |
| CN113897356B (zh) * | 2021-10-20 | 2024-04-30 | 佛山科学技术学院 | 一种检测鸡传染性贫血病毒荧光定量pcr试剂盒及引物 |
| TW202529819A (zh) | 2023-10-13 | 2025-08-01 | 美商旗艦先鋒創新公司 | 組織特異性指環載體(anellovector)遞送 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030138443A1 (en) * | 1993-03-08 | 2003-07-24 | Noteborn Mathews H.M. | Cloning of chicken anemia virus DNA |
| US6162461A (en) * | 1990-09-12 | 2000-12-19 | Leadd B.V. | Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| US9862760B2 (en) * | 2015-09-16 | 2018-01-09 | Novartis Ag | Polyomavirus neutralizing antibodies |
| GB201701239D0 (en) * | 2017-01-25 | 2017-03-08 | Glaxosmithkline Biologicals Sa | Novel formulation |
| US20230048858A1 (en) * | 2018-12-12 | 2023-02-16 | Flagship Pioneering Innovations V, Inc. | Anellosomes for delivering secreted therapeutic modalities |
-
2021
- 2021-10-29 US US18/250,621 patent/US20240000914A1/en not_active Abandoned
- 2021-10-29 IL IL302332A patent/IL302332A/en unknown
- 2021-10-29 KR KR1020237017993A patent/KR20230093326A/ko not_active Withdrawn
- 2021-10-29 WO PCT/US2021/057292 patent/WO2022094238A2/en not_active Ceased
- 2021-10-29 AU AU2021372533A patent/AU2021372533A1/en not_active Abandoned
- 2021-10-29 CA CA3199750A patent/CA3199750A1/en active Pending
- 2021-10-29 EP EP21887615.9A patent/EP4237567A4/en not_active Withdrawn
- 2021-10-29 MX MX2023005040A patent/MX2023005040A/es unknown
- 2021-10-29 TW TW110140471A patent/TW202233652A/zh unknown
- 2021-10-29 JP JP2023526256A patent/JP2023548838A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022094238A2 (en) | 2022-05-05 |
| AU2021372533A9 (en) | 2024-07-11 |
| IL302332A (en) | 2023-06-01 |
| CA3199750A1 (en) | 2022-05-05 |
| JP2023548838A (ja) | 2023-11-21 |
| AU2021372533A1 (en) | 2023-06-01 |
| US20240000914A1 (en) | 2024-01-04 |
| EP4237567A4 (en) | 2025-01-15 |
| WO2022094238A3 (en) | 2022-06-09 |
| EP4237567A2 (en) | 2023-09-06 |
| TW202233652A (zh) | 2022-09-01 |
| KR20230093326A (ko) | 2023-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022094238A3 (en) | Chicken anemia virus (cav)-based vectors | |
| GEP20227374B (en) | Novel, highly active pyrazolo-piperidine substituted indole-2-carboxamides active against the hepatitis b virus (hbv) | |
| MX2022013878A (es) | Composiciones detergentes que contienen un surfactante ramificado. | |
| WO2020198403A3 (en) | Compositions comprising modified circular polyribonucleotides and uses thereof | |
| MX2021000965A (es) | Composiciones que comprenden polirribonucleotidos circulares y usos de estas. | |
| MX2022012955A (es) | Composiciones de trem y usos de las mismas. | |
| MX2020006358A (es) | Masas moldeables de poliamida modificadas a resistencia elevada a los choques. | |
| ZA202403101B (en) | Antiviral prodrugs and nanoformulations thereof | |
| ZA202106602B (en) | Claudin 6 antibodies and uses thereof | |
| MX2022015755A (es) | Profarmacos de hormona paratiroidea (pth). | |
| EA201992177A1 (ru) | Композиции на основе нирапариба | |
| MY198425A (en) | Glp-1 Compositions and uses Thereof | |
| PH12017501863A1 (en) | Bioconjugates and uses thereof | |
| BR112017018735A2 (pt) | aperfeiçoamentos em ou relacionados a compostos orgânicos | |
| MX2022003365A (es) | Anticuerpos de un solo dominio dirigidos contra lilrb2. | |
| MX2020001969A (es) | Composiciones de reduccion del mal olor. | |
| BR112018009837A8 (pt) | composição catalítica e composição curável | |
| ZA201708618B (en) | Indane derivatives for malodor counteraction | |
| MX2022006776A (es) | Composiciones farmaceuticas oftalmicas. | |
| MX2022005362A (es) | Composiciones de trem para codones con-raros y usos relacionados. | |
| MX2024000931A (es) | Metodos para preparar composiciones que comprenden un constituyente, derivado o extracto de cannabis. | |
| PH12021550441A1 (en) | Modified pedv spike protein | |
| MX2024004492A (es) | Composiciones y metodos de anellovector novedosos. | |
| PH12018501183B1 (en) | Method of preparing porcine circovirus type 2 capsid protein and pharmaceutical composition comprising same | |
| WO2023114857A3 (en) | Surface-modified viral particles and modular viral particles |